Resources
-
The Fine Art of Destruction for In-Depth Mass Spectrometry-Based Glycoproteomics: Advances in Measurement and Data Analysis — Exploiting the Diagnostic Potential of Fragment Ions
Speaker Presentation Rapp Erdmann Max Planck Institute for Dynamics of Complex Technical Systems 2022
-
Considerations for the Application of Multi-Attribute-Method (MAM) by Mass Spectrometry for QC Release and Stability Testing of Biopharmaceuticals
Speaker Presentation Pohl Thomas Novartis 2022
-
Accelerating Global Supply of Vaccines –Lessons Learnt
Speaker Presentation Pellet Mark AstraZeneca 2022
-
Regulatory Experience from the Rolling Review Process and the Conditional Marketing Authorisation Process for COVID-19 Vaccines
Speaker Presentation Pedone Elisa European Medicines Agency 2022
-
The Case for Revision to the ICH Stability Guidelines: An Industry Perspective
Speaker Presentation Lennard Andrew Amgen Inc. 2022
-
Transmission Electron Microscopy - Utilising a Powerful Tool in Biosafety as a Novel Approach
Speaker Presentation Layland Ashely neotem Bioanalytics 2022
-
The Future is Now: ICH Q14: Analytical Procedure Development ICH Q2(R2): Validation of Analytical Procedures
Speaker Presentation Keire David CDER, FDA 2022
-
Strategies of Overcoming Risks of Changing Analytical Methods
Speaker Presentation Gellermann Gerald Novartis 2022
-
Capillary Electrophoresis and Taylor Dispersion Analysis for the Characterization of mRNA Vaccines
Speaker Presentation Cottet Hervé IBMM, Université de Montpellier 2022
-
Development of New Ph. Eur. “Horizontal Standards” for Monoclonal Antibody Analysis: An Overview from the EDQM
Speaker Presentation Buda Mihaela EDQM 2022
-
Cutting-Edge Multi-Level Analytical and Structural Characterization of Antibody-Based Therapeutics
Speaker Presentation Beck Alain Pierre Fabre Group 2022
-
Biological Reference Standards for Multivalent Vaccines - Qualification, Strategies and Challenges From a National Control Lab Perspective
Speaker Presentation Tesolin Lorenzo Sciensano 2020
-
Double Duty Bioassays: A Regulatory
Perspective on Bispecific Antibody
Bioassay Development
Speaker Presentation Nickens Kristen US FDA 2020
-
Development and Qualification of a Potency Assay to Support Gene Therapy
Speaker Presentation Maheno Hannah Sanofi 2020
-
Flow into the Future - The Importance of Flow Cytometry Methods in Engineered T Cell Therapies
Speaker Presentation Lowe Emily Kite 2020
-
Moroccan Good Regulatory Practices: Regulatory and Technical Requirements for the Registration of Medicines for Human Use in Morocco
Speaker Presentation Lakhlili Wiame DMP 2020
-
A Shared Framework for Protein Analytics; Bioassays Enhancing Drug Development
Speaker Presentation Kozlowski Steven CDER FDA 2020
-
Curve Similarity Index for Testing Parallelism in Bioassay
Speaker Presentation Faya Paul Eli Lilly 2020
-
Critical Reagents in Bioassay - Their Importance, Characterization and Storage
Speaker Presentation Asara Nana Charles River Laboratories 2020
-
The USP Bioassay Chapters: Out with the Old, In with the New
Speaker Presentation Walfish Steven USP 2019